Xtant Medical Holdings (XTNT) Tops Q4 EPS by 1c ; Offers Guidance

Xtant Medical Holdings (NYSE: XTNT) reported Q4 EPS of $0.00, $0.01 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $32.36 million versus the consensus estimate of $30.75 million.

GUIDANCE:

Xtant Medical Holdings sees FY2026 revenue of $95-99 million, versus the consensus of $110.1 million.

For earnings history and earnings-related data on Xtant Medical Holdings (XTNT) click here.

You May Also Be Interested In

• Fox upgraded to overweight as Roku deal, ad strength lift outlook
• Sphere 3D posts $13.8M Q2 loss after Cathedra merger
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c